Inotiv (NOTV)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Inotiv (NOTV)
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
Key Insights
Critical company metrics and information
Share Price
$3.93Market Cap
$102.20 MillionTotal Outstanding Shares
26.00 Million SharesTotal Employees
2,055Dividend
No dividendIPO Date
November 25, 1997SIC Description
Services-commercial Physical & Biological ResearchHomepage
https://www.inotivco.com
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
April 1, 2024 to June 30, 2024
| Metric | Value |
|---|---|
| Exchange Gains/Losses | $293000.00 |
| Net Cash Flow | $-18.26 Million |
| Net Cash Flow From Financing Activities, Continuing | $795000.00 |
| Net Cash Flow From Operating Activities, Continuing | $-14.81 Million |
| Net Cash Flow From Operating Activities | $-14.81 Million |
| Net Cash Flow From Investing Activities, Continuing | $-2.95 Million |
| Net Cash Flow, Continuing | $-18.55 Million |
| Net Cash Flow From Financing Activities | $795000.00 |
| Net Cash Flow From Investing Activities | $-2.95 Million |
Income Statement
April 1, 2024 to June 30, 2024
| Metric | Value |
|---|---|
| Basic Earnings Per Share | $1.00 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Revenues | $105.79 Million |
| Depreciation and Amortization | $14.12 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss | $-26.09 Million |
| Diluted Earnings Per Share | $1.00 |
| Income/Loss From Continuing Operations After Tax | $-26.09 Million |
| Income/Loss From Continuing Operations Before Tax | $-32.95 Million |
| Other Operating Expenses | $112.42 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $-26.09 Million |
| Net Income/Loss Attributable To Parent | $-26.09 Million |
| Operating Expenses | $126.54 Million |
| Diluted Average Shares | $25.99 Million |
| Basic Average Shares | $25.99 Million |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Operating Income/Loss | $-20.75 Million |
| Income Tax Expense/Benefit | $-6.86 Million |
| Costs And Expenses | $138.74 Million |
| Benefits Costs and Expenses | $138.74 Million |
Balance Sheet
April 1, 2024 to June 30, 2024
| Metric | Value |
|---|---|
| Liabilities And Equity | $774.59 Million |
| Accounts Payable | $28.32 Million |
| Assets | $774.59 Million |
| Current Liabilities | $485.07 Million |
| Other Current Liabilities | $456.75 Million |
| Noncurrent Assets | $625.36 Million |
| Fixed Assets | $189.70 Million |
| Other Current Assets | $110.55 Million |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity | $182.11 Million |
| Long-term Debt | $382.45 Million |
| Inventory | $38.68 Million |
| Other Non-current Assets | $435.65 Million |
| Equity Attributable To Parent | $182.11 Million |
| Liabilities | $592.48 Million |
| Noncurrent Liabilities | $107.41 Million |
| Current Assets | $149.23 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.